Metraipolis › archive › dc_48620b6eedbd

Comparative Efficacy and Safety of Resmetirom and Efruxifermin for Metabolic Dysfunction-Associated Steatohepatitis: A Network Meta-Analysis of Randomized… — Europe PMC PMID:41947319

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41947319
DOI
10.1002/edm2.70218
License (as archived)
solo-consultazione
Archived
2026-10-08T06:16:09.400Z
SHA-256 of the archived text
c6b51f47dc5d85e9a5415d243e9950e70ae95756400cf0315b65e09feb865240
Stable URL of this page
https://metraipolis.com/documento/dc_48620b6eedbd

How to cite

Comparative Efficacy and Safety of Resmetirom and Efruxifermin for Metabolic Dysfunction-Associated Steatohepatitis: A Network Meta-Analysis of Randomized… — Europe PMC PMID:41947319 — Europe PMC (en), https://europepmc.org/article/MED/41947319 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_48620b6eedbd (Metraipolis archive dc_48620b6eedbd, sha256 c6b51f47dc5d85e9a5415d243e9950e70ae95756400cf0315b65e09feb865240)
BibTeX
@misc{dc48620b6eedbd,
  title = {Comparative Efficacy and Safety of Resmetirom and Efruxifermin for Metabolic Dysfunction-Associated Steatohepatitis: A Network Meta-Analysis of Randomized… — Europe PMC PMID:41947319},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41947319},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_48620b6eedbd; sha256 c6b51f47dc5d85e9a5415d243e9950e70ae95756400cf0315b65e09feb865240},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41947319. Agents can read the archived copy with the MCP tool read_document.